Amends the Internal Revenue Code to provide that the term "taxable vaccine" shall apply to any vaccine against hepatitis A manufactured or produced in the United States or brought into the United States for consumption, use, or warehousing, thus providing that the vaccine excise tax shall apply to such vaccines.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.